Month: September 2021

TNFα-supplemented DL-4 culture system supports first-in-clinic Smart Immune ProTcell™ technology for immuno-deficient patients fighting cancers and infections

Rapid reset of immune system can provide marked benefits in clinical settings where patients are…

Mountain Valley MD Holdings Announces Letter of Intent with Red White and Bloom Brands Inc.

TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…

Enlivex to Present at Reuters Events’ Cell & Gene Therapy USA 2021

Nes-Ziona, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…

Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021

MONTREAL, Sept. 29, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a…

SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp

Subpopulation analysis of 74 patients from ongoing Phase 3 FURI study demonstrated similar efficacy against…

Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society

Data from two different studies benchmark Duet’s proprietary bifunctional oligonucleotides against immune checkpoint inhibitors (“Checkpoint…

Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expansion and Exceeds Regulatory Expectations

BURBANK, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy

Trial is expected to enroll 15 boys with DMD amenable to exon 53 skipping First…

Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

BOTHELL, Wash., Sept. 29, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late…

Immutep Receives A$3.4 million R&D Tax Incentive from French Government

SYDNEY, AUSTRALIA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“…

Krystal Biotech Receives Approval from the Human Research Ethics Committee in Australia for Phase 1 Trial of KB407 for Cystic Fibrosis

– KB407 is an investigational inhaled gene therapy derived from Krystal’s clinically validated redosable gene…

Neoleukin Therapeutics Announces Oral Presentation at IDWeek 2021 of Data Demonstrating that NL-CVX1, a Computationally Designed De Novo Protein, Can Block Infection by SARS-CoV-2 Viral Variants of Concern

– Single intranasal dose of NL-CVX1 in mice prevents infection by multiple variants of SARS-CoV-2…

Month: September 2021

TNFα-supplemented DL-4 culture system supports first-in-clinic Smart Immune ProTcell™ technology for immuno-deficient patients fighting cancers and infections

Mountain Valley MD Holdings Announces Letter of Intent with Red White and Bloom Brands Inc.

Enlivex to Present at Reuters Events’ Cell & Gene Therapy USA 2021

Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021

SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp

Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society

Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expansion and Exceeds Regulatory Expectations

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy

Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Immutep Receives A$3.4 million R&D Tax Incentive from French Government

Krystal Biotech Receives Approval from the Human Research Ethics Committee in Australia for Phase 1 Trial of KB407 for Cystic Fibrosis

Neoleukin Therapeutics Announces Oral Presentation at IDWeek 2021 of Data Demonstrating that NL-CVX1, a Computationally Designed De Novo Protein, Can Block Infection by SARS-CoV-2 Viral Variants of Concern

Kolab Project Launches 132 Series Live Resin Soft Chews, Canada’s First Live Resin Cannabis Edible

Allena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346

Cidara Therapeutics to Present New Data for Rezafungin at TIMM Congress

BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies

Starter to Host IDO of Blockchain Gaming Platform Enjinstarter

Sumo Logic Addresses Digital Transformation Complexity Driven By Exponential Growth of Digital Services

Organization for Ethical Source Launches Hippocratic License 3.0, Strengthening Enforcement and Adding Flexibility

The .CA Domain Squad ventures into the great outdoors on CIRA’s new advertising campaign

You may have missed

Williams Racing Chooses Keeper Security to Safeguard Data in Formula 1’s High-Stakes, Data-Driven World

DesignInspire opens on December 5, with free admission for the public

Mailbird Expands to Mac: Popular Windows Email Client Launches Much-Anticipated Mac App

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities